• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Study finds children with residual amblyopia did not find an advantage with levodopa

Article

A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA.

Baltimore-A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA. 

 

Read the results of the study here.

Related Videos
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
© 2024 MJH Life Sciences

All rights reserved.